City

Bethesda (1)

Caen (1)

Paris (1)

Condition

Muscular Dystrophy, Oculopharyngeal (3)

Cardiomyopathy, Hypertrophic (1)

Ptosis (1)

Overall Status

Completed (2)

Terminated (1)

Sign in for free

Phase

phase 2 (1)

phase 2/phase 3 (1)

Sponsor

Assistance Publique - Hopitaux de Paris (1)

National Heart, Lung, and Blood Institute (NHLBI) (1)

University Hospital, Caen (1)

Collaborator

Association Francaise contre les Myopathies (AFM), Paris (1)

Centre Hospitalier Universitaire, Amiens (1)

Groupe Hospitalier Pitie-Salpetriere (1)

Rennes University Hospital (1)

University Hospital, Brest (1)

University Hospital, Lille (1)

University Hospital, Rouen (1)

Intervention

autologous myoblasts transplantation and myotomy (1)

myoblast autologous graft (1)

Study Documents

Intervention Type

biological (1)

procedure (1)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (2)

Observational (1)

muscular dystrophy, oculopharyngeal

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Muscular Dystrophy, Oculopharyngeal, Ptosis Trial in Caen (Myoblast autologous graft)

Terminated

Muscular Dystrophy, Oculopharyngeal
Ptosis

Myoblast autologous graft

Caen, France

CHU Caen

Nov 23, 2020

Muscular Dystrophy, Oculopharyngeal Trial in Paris (Autologous myoblasts transplantation and myotomy)

Completed

Muscular Dystrophy, Oculopharyngeal

Autologous myoblasts transplantation and myotomy

Paris, France

Hospital Tenon

Nov 19, 2015

Muscle Abnormalities in Patients With Specific Genetic Mutations

Completed

Cardiomyopathy, Hypertrophic
Muscular Dystrophy, Oculopharyngeal

Bethesda, Maryland

National Heart, Lung and Blood Institute (NHLBI)

Mar 3, 2008